Fentanyl Citrate Injection Recall Due to Lack of Sterility Assurance
Nephron Sterile Compounding Center is recalling Fentanyl Citrate Injection nationwide due to lack of assurance of sterility. Approximately 9,410 bags distributed to healthcare facilities are affected.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall of a high-risk injectable product. Per the rubric, it scores High (3) as a risk-of-harm product where no illnesses or injuries are reported in the source text.
Plain-English summary
Nephron Sterile Compounding Center LLC is recalling Fentanyl Citrate in 0.9% Sodium Chloride Injection, USP, supplied as 2500 mcg/250 mL (10 mcg/mL) bags in cases of 10 bags each. This is a prescription-only injectable medication manufactured at the Nephron 503B outsourcing facility in West Columbia, South Carolina.
The recall was initiated due to lack of assurance of sterility. The affected lot numbers are FN2001A and FN2001B (expiration date 7/8/2022), FN2002A and FN2002B (expiration date 7/19/2022), and FN2003A and FN2003B (expiration date 8/24/2022).
Approximately 9,410 bags were distributed nationwide in the United States. Healthcare facilities and providers who received these affected lots should verify their inventory and take appropriate action to prevent use of the recalled product.
For injectable medications, lack of sterility assurance presents a potential risk of microbial contamination that could result in infection. Any adverse events associated with use of this product should be reported to the FDA immediately.
The recalled product
- Product
- Fentanyl Citrate in 0.9% Sodium Chloride Injection, USP, 2500 mcg/250 mL (10 mcg/mL*) bags, packaged as 10 x 1 IV bag per case, Rx Only, Nephron 503B outsourcing facility, 4500 12th St. Extension, West Columbia, SC 29172, NDC: 69374-523-21
- Manufacturer
- Nephron Sterile Compounding Center LLC
- Category
- Drug — Injectable
- Affected units
- 9,410
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (9)
- Lots: FN2001A
- Exp. 7/8/2022
- FN2001B
- FN2002A
- Exp. 7/19/2022
- FN2002B
- FN2003A
- Exp. 8/24/2022
- FN2003B
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 37 recalled by Nephron Sterile Compounding Center LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 37 products in this recall →Related recalls
Same manufacturer · Nephron Sterile Compounding Center LLC
See all →- HighSodium Chloride Injection Recalled for Potential Sterility Compromise
FDA (Drugs) · 2025-03-19
- HighNorepinephrine Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2023-03-08
- HighNephron Phenylephrine HCl Injection Recalled for Sterility Assurance
FDA (Drugs) · 2023-03-08
- HighDiltiazem HCl Injectable Drug Recalled for Sterility Assurance Failure
FDA (Drugs) · 2023-03-08
- HighFDA Recalls Norepinephrine Injection Due to Sterility Concerns
FDA (Drugs) · 2023-03-08
Same hazard · lack of sterility
See all →- HighRohto Cooling Eye Drops Max Strength Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- HighRohto Cooling Eye Drops Recalled Due to Lack of Assurance of Sterility
FDA (Drugs) · 2026-07-29
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- SeverePemetrexed for Injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-07-15
- SevereAzacitidine for Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2026-07-15